Since the onset of ovarian cancer among BRCA2 mutation carriers is approximately 8 to 10 years later than in BRCA1 mutation carriers, the recommended timing of RRBSO is delayed to ages 40 to 45 [18]. This evidence concerns the gene BRCA1 and ovarian cancer.